Tuesday, August 30, 2016

BRIEF-Relypsa says Phase 4 TOURMALINE study meets primary endpoint

* Announces phase 4 study shows veltassa demonstrated

similar efficacy and safety whether given with or without food

in patients with hyperkalemia

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)